All for Joomla All for Webmasters

Author Archives: MyBioGate

China’s changing pharmaceutical E-commerce market

“China’s changing pharmaceutical E- commerce market” is developed by Deloitte China Life Sciences and Health Care Industry, Technology, Media & Telecommunications Industry in collaboration with Deloitte Research. The technology of mobile Internet and E-commerce has promoted the industry crossover, and driven the traditional industries into the era of restructuring. It is inevitable to realize the […]

Excellence in Medical Affair: Recent trends in China Medical Affairs and Outcomes from China Medical Affairs Survey 2016

The report “Excellence in Medical Affair: Recent trends in China Medical Affairs and Outcomes from China Medical Affairs Survey 2016” is developed by Deloitte China Life Sciences and Health Care Industry team. As the roles of Medical Affairs have become increasingly important in driving business growth, the China Medical Affairs Network (CMAN) conducted a survey […]

As National Party Congress concludes, China’s FDA seeks to write widely-anticipated drug reforms into law

In a bid to move Chinese drug industry regulations closer to the US/European model, China’s FDA yesterday proposed significant changes to the nation’s Drug Administration Act. The widely expected move comes on the heels of instructions given two weeks ago by the reigning State Council, China’s cabinet, just prior to the 19th Communist Party Congress […]

Chinese Government Initiates Significant Drug and Device Regulatory Reforms

China has recently announced several initiatives to reform its regulation of drugs and medical devices that could have a significant impact on pharmaceutical and medical device companies doing business in China. On October 8, 2017, the General Office of Chinese CommunistParty’s Central Committee and the General Office of China’s State Council jointly announced an Opinion […]

China’s NDRC seeks public comments on important outbound investment regulatory changes

On 3 November 2017, the National Development and Reform Commission (“NDRC”), one of China’s key outbound investment regulatory bodies, has issued the Announcement on Seeking Public Comments on the Administrative Measures for Outbound Investment of Enterprises (Draft for Comment) (the “Draft”). The Draft was prepared in light of the Guiding Opinions on Further Guiding and […]

China drafts new rule to improve management of outbound investment

BEIJING, Nov. 3 (Xinhua) — China’s top economic planner Friday released a new draft rule to simplify administrative procedures and strengthen regulation on outbound investment by Chinese firms. The new rule will scrap a provision from a previous rule implemented in 2014 that requires companies acquiring or bidding for overseas projects valued at over 300 […]

Funding for medical innovation in the US is declining

In 2016, US venture capital, private equity, and medtech firms invested the lowest amount in four years in medical device companies according to Silicon Valley Bank(SVB)). Investments in medical device companies in 2017 are forecasted to drop as investors shift their focus to software and IT industries. As funding for medical technology companies fall in […]